{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:55:50Z","timestamp":1791140150898,"version":"4.1.0"},"reference-count":212,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.arcmed.2014.11.020","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T01:30:32Z","timestamp":1417656632000},"page":"711-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Cyclodextrins, Blood\u2013Brain Barrier, and Treatment of Neurological Diseases"],"prefix":"10.1016","volume":"45","author":[{"given":"Mikl\u00f3s","family":"Vecserny\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Fenyvesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"B\u00e1cskay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria A.","family":"Deli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Szente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Fenyvesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2014.11.020_bib1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.arcmed.2014.11.020_bib2","series-title":"Solubility, Delivery, and ADME Problems of Drugs and Drug-Candidates","first-page":"144","article-title":"Drug transport and the blood-brain barrier","author":"Deli","year":"2011"},{"key":"10.1016\/j.arcmed.2014.11.020_bib3","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/jps.20992","article-title":"Effects of cyclodextrins on drug delivery through biological membranes","volume":"96","author":"Loftsson","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.2042-7158.2011.01279.x","article-title":"Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes","volume":"63","author":"Loftsson","year":"2011","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib5","series-title":"Cyclodextrin Technology","author":"Szejtli","year":"1988"},{"key":"10.1016\/j.arcmed.2014.11.020_bib6","series-title":"Comprehensive Supramolecular Chemistry, Volume 3: Cyclodextrins","year":"1996"},{"key":"10.1016\/j.arcmed.2014.11.020_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0040-6031(01)00665-7","article-title":"Thermal analysis of cyclodextrins and their inclusion compounds","volume":"380","author":"Giordano","year":"2001","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.arcmed.2014.11.020_bib8","first-page":"8","article-title":"A literature review of cyclodextrin inclusion complexes characterization. Part II: X-ray diffraction, infrared spectroscopy and nuclear magnetic resonance","volume":"12","author":"Takahashi","year":"2012","journal-title":"Int J Pharm Sci Rev Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib9","series-title":"Cyclodextrins and Their Complexes","first-page":"289","article-title":"Circular dichroism of cyclodextrin complexes","author":"Krois","year":"2008"},{"key":"10.1016\/j.arcmed.2014.11.020_bib10","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1021\/ac400639y","article-title":"Cyclodextrins in analytical chemistry: host-guest type molecular recognition","volume":"85","author":"Szente","year":"2013","journal-title":"Anal Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-4347(00)00057-8","article-title":"Cyclodextrins: a versatile tool in separation science","volume":"745","author":"Schneiderman","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.arcmed.2014.11.020_bib12","first-page":"283","article-title":"Cyclodextrins and molecular encapsulation","volume":"2","author":"Szejtli","year":"2004"},{"key":"10.1016\/j.arcmed.2014.11.020_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4155\/tde.12.28","article-title":"Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms","volume":"3","author":"Arima","year":"2012","journal-title":"Ther Deliv"},{"key":"10.1016\/j.arcmed.2014.11.020_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/10611861003622552","article-title":"Cyclodextrins for drug delivery","volume":"18","author":"Laza-Knoerr","year":"2010","journal-title":"J Drug Target"},{"key":"10.1016\/j.arcmed.2014.11.020_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/157340106778699485","article-title":"Cyclodextrins as food additives and in food processing","volume":"2","author":"Cravotto","year":"2006","journal-title":"Curr Nutr Food Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib17","first-page":"15","article-title":"Cyclodextrins and their use in pharmacy and cosmetology","volume":"19","author":"Duchene","year":"2009","journal-title":"STP Pharma Pratiques"},{"key":"10.1016\/j.arcmed.2014.11.020_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10847-010-9909-y","article-title":"Cyclodextrins in innovative engineering tools for risk-based environmental management","volume":"70","author":"Gruiz","year":"2011","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib19","series-title":"Comprehensive Supramolecular Chemistry, Volume 3: Cyclodextrins","first-page":"423","article-title":"Applications of cyclodextrins in biotechnology","author":"Bar","year":"1996"},{"key":"10.1016\/j.arcmed.2014.11.020_bib20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/js9704341","article-title":"Spontaneous opalescence of aqueous \u03b3-cyclodextrin solutions: complex formation or self-aggregation?","volume":"87","author":"Szente","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib21","series-title":"Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine","first-page":"199","article-title":"Amphiphilic cyclodextrins: synthesis and characterization","author":"Perret","year":"2011"},{"key":"10.1016\/j.arcmed.2014.11.020_bib22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/js960075u","article-title":"Pharmaceutical applications of cyclodextrins. 2. In\u00a0vivo drug delivery","volume":"85","author":"Rajewski","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/03639049809088532","article-title":"Evaluation of a sulfobutyl ether \u03b2-cyclodextrin as a solubilizing\/stabilizing agent for several drugs","volume":"24","author":"Ueda","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-409X(98)00092-1","article-title":"Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development","volume":"36","author":"Szente","year":"1999","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.arcmed.2014.11.020_bib25","first-page":"94","article-title":"The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems","volume":"57","author":"Brewster","year":"2002","journal-title":"Pharmazie"},{"key":"10.1016\/j.arcmed.2014.11.020_bib26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/jps.23917","article-title":"Methyl-beta-cyclodextrins: the role of number and types of substituents in solubilizing power","volume":"103","author":"Fenyvesi","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib27","first-page":"117","article-title":"Phase-solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv Anal Chem Instrum"},{"key":"10.1016\/j.arcmed.2014.11.020_bib28","unstructured":"Fenyvesi \u00c9, Vikmon AM, Szente L. Cyclodextrins in Food Technology and Human Nutrition: Benefits and Limitations in 2012. Crit Rev Food Sci Nutr; [Epub ahead of print]."},{"key":"10.1016\/j.arcmed.2014.11.020_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1248\/cpb.51.1253","article-title":"Interactions of cholesterol with cyclodextrins in aqueous solution","volume":"51","author":"Nishijo","year":"2003","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.arcmed.2014.11.020_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1248\/bpb1978.5.741","article-title":"Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in\u00a0vitro","volume":"5","author":"Irie","year":"1982","journal-title":"J Pharmacobiodyn"},{"key":"10.1016\/j.arcmed.2014.11.020_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1432-1033.1989.tb15171.x","article-title":"Differential effects of \u03b1-, \u03b2- and \u03b3-cyclodextrins on human erythrocytes","volume":"186","author":"Ohtani","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1248\/bpb.32.700","article-title":"Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated \u03b2-cyclodextrins","volume":"32","author":"Motoyama","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.arcmed.2014.11.020_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejps.2010.04.014","article-title":"Evaluation of the cytotoxicity of \u03b2-cyclodextrin derivatives: evidence for the role of cholesterol extraction","volume":"40","author":"Kiss","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib34","first-page":"557","article-title":"Cytotoxicity of different types of methylated \u03b2-cyclodextrins and ionic derivatives","volume":"62","author":"Kiss","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/j.arcmed.2014.11.020_bib35","doi-asserted-by":"crossref","first-page":"17250","DOI":"10.1074\/jbc.270.29.17250","article-title":"Cellular cholesterol efflux mediated by cyclodextrins","volume":"270","author":"Kilsdonk","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-5173(94)90080-9","article-title":"Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivatives","volume":"101","author":"Leroy-Lechat","year":"1994","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2009.01.019","article-title":"Sparing methylation of beta-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in\u00a0vitro","volume":"136","author":"Salem","year":"2009","journal-title":"J Contr Rel"},{"key":"10.1016\/j.arcmed.2014.11.020_bib38","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1074\/jbc.271.27.16026","article-title":"Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux","volume":"271","author":"Yancey","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib39","series-title":"Methods in Molecular Biology, Vol. 400: Methods in Membrane Lipids","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-1-59745-519-0_30","article-title":"Detergent and detergent-free methods to define lipid rafts and caveolae","author":"Ostrom","year":"2007"},{"key":"10.1016\/j.arcmed.2014.11.020_bib40","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2014.11.020_bib41","series-title":"Methods in Molecular Biology, Vol. 398: Lipid Rafts","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-59745-513-8_13","article-title":"Fluorescence recovery after photobleaching studies of lipid rafts","author":"Kenworthy","year":"2007"},{"key":"10.1016\/j.arcmed.2014.11.020_bib42","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0022-2275(20)34940-3","article-title":"Use of cyclodextrins for manipulating cellular cholesterol content","volume":"38","author":"Christian","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/psc.678","article-title":"Investigation of penetratin peptides. Part 2. In\u00a0vitro uptake of penetratin and two of its derivatives","volume":"11","author":"Letoha","year":"2005","journal-title":"J Peptide Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1874372200903010163","article-title":"Lipid rafts and keratinocyte apoptosis: regulation via death receptors and Akt","volume":"3","author":"Gniadecki","year":"2009","journal-title":"Open Dermatol J"},{"key":"10.1016\/j.arcmed.2014.11.020_bib45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1023\/B:PHAM.0000022409.27896.d4","article-title":"Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-\u03b2-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers","volume":"21","author":"Arima","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejps.2008.04.005","article-title":"P-glycoprotein inhibition by membrane cholesterol modulation","volume":"34","author":"Fenyvesi","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib47","doi-asserted-by":"crossref","first-page":"e103122","DOI":"10.1371\/journal.pone.0103122","article-title":"Cholesterol selectively regulates IL-5 induced mitogen activated protein kinase signaling in human eosinophils","volume":"9","author":"Burnham","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2014.11.020_bib48","series-title":"Subcellular Biochemistry, Vol. 37: Membrane Dynamics and Domains","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4757-5806-1_5","article-title":"Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications","author":"Barenholz","year":"2004"},{"key":"10.1016\/j.arcmed.2014.11.020_bib49","doi-asserted-by":"crossref","first-page":"e1002020","DOI":"10.1371\/journal.pcbi.1002020","article-title":"Molecular mechanism of cyclodextrin mediated cholesterol extraction","volume":"7","author":"L\u00f3pez","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib50","first-page":"127","article-title":"Effect of cholesterol on the motility and plasma membrane integrity of frozen equine spermatozoa after thawing","volume":"56","author":"Combes","year":"2000","journal-title":"J Reprod Fertil Suppl"},{"key":"10.1016\/j.arcmed.2014.11.020_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cryobiol.2010.05.006","article-title":"Effects of cholesterol-loaded cyclodextrin during freezing step of cryopreservation with TCGY extender containing bovine serum albumin on quality of goat spermatozoa","volume":"61","author":"Amidi","year":"2010","journal-title":"Cryobiology"},{"key":"10.1016\/j.arcmed.2014.11.020_bib52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.anireprosci.2009.06.013","article-title":"Treating ram sperm with cholesterol-loaded cyclodextrins improves cryosurvival","volume":"118","author":"Moce","year":"2010","journal-title":"Animal Reprod Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib53","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","article-title":"Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery","volume":"1788","author":"Deli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2014.11.020_bib54","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1471-4159.1990.tb01236.x","article-title":"An easier, reproducible, and mass-production method to study the blood-brain barrier in\u00a0vitro","volume":"54","author":"Dehouck","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(98)00083-0","article-title":"In\u00a0vitro model for evaluating drug transport across the blood-brain barrier","volume":"36","author":"Cecchelli","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.arcmed.2014.11.020_bib56","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.bmcl.2006.01.049","article-title":"Methylated \u03b2-cyclodextrin as P-gp modulators for deliverance of doxorubicin across in\u00a0vitro model of the blood-brain barrier","volume":"16","author":"Tilloy","year":"2006","journal-title":"Biorg Med Chem Lett"},{"key":"10.1016\/j.arcmed.2014.11.020_bib57","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/jpet.104.071845","article-title":"Effect of \u03b3- and hydroxypropyl-\u03b3-cyclodextrins on the transport of doxorubicin across an in\u00a0vitro model of blood-brain barrier","volume":"311","author":"Monnaert","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.arcmed.2014.11.020_bib58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bm801026k","article-title":"Quaternary ammonium \u03b2-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the\u00a0in\u00a0vitro blood-brain barrier","volume":"10","author":"Gil","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.arcmed.2014.11.020_bib59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.arcmed.2014.11.020_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2008.01.043","article-title":"In\u00a0vivo antiviral activity of ribavirin\/alpha-cyclodextrin complex: evaluation on experimental measles virus encephalitis model in mice","volume":"357","author":"Jeulin","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.antiviral.2008.12.006","article-title":"Effective ribavirin concentration in mice brain using cyclodextrin as a drug carrier: evaluation in a measles encephalitis model","volume":"81","author":"Jeulin","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.patbio.2006.07.008","article-title":"Evaluation by Q-RTPCR of the efficacy of ribavirin complexed with beta-cyclodextrin against measles virus in a mouse encephalitis model","volume":"54","author":"Jeulin","year":"2006","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.arcmed.2014.11.020_bib63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2013.10.005","article-title":"A novel lactoferrin-modified \u03b2-cyclodextrin nanocarrier for brain-targeting drug delivery","volume":"458","author":"Ye","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib64","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/jps.2600771118","article-title":"Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins","volume":"77","author":"Brewster","year":"1988","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib65","first-page":"287","article-title":"Brain-enhanced delivery of testosterone using a chemical delivery system complexed with 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"2","author":"Anderson","year":"1988","journal-title":"Drug Des Deliv"},{"key":"10.1016\/j.arcmed.2014.11.020_bib66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jps.2600830615","article-title":"Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles","volume":"83","author":"Pitha","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000125196","article-title":"Evidence for prolonged suppression of stress-induced release of adrenocorticotropic hormone and corticosterone with a brain-enhanced dexamethasone-redox delivery system","volume":"50","author":"Anderson","year":"1989","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arcmed.2014.11.020_bib68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0024-3205(91)90537-L","article-title":"The utility of 2-hydroxypropyl-\u03b2-cyclodextrin as a vehicle for the intracerebral and intrathecal administration of drugs","volume":"48","author":"Yaksh","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-3565(25)11080-X","article-title":"Use of 2-hydroxypropyl-\u03b2-cyclodextrin as an intrathecal drug vehicle with opioids","volume":"261","author":"Jang","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.arcmed.2014.11.020_bib70","first-page":"e1308","article-title":"Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis","volume":"5","author":"Rodgers","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2014.11.020_bib71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0960-894X(00)80675-7","article-title":"A new approach to enhance bioavailability of biologically active peptides: conjugation of a \u03b4 opioid agonist to \u03b2-cyclodextrin","volume":"3","author":"Hristova-Kazmierski","year":"1993","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.arcmed.2014.11.020_bib72","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1208\/s12249-011-9685-z","article-title":"Sulfobutyl ether7 \u03b2-cyclodextrin (SBE7 \u03b2-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in\u00a0vivo anti-epileptic activity","volume":"12","author":"Jain","year":"2011","journal-title":"AAPS PharmSci Tech"},{"key":"10.1016\/j.arcmed.2014.11.020_bib73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.104.067512","article-title":"Behavior of \u03b1-, \u03b2-, and \u03b3-cyclodextrins and their derivatives on an in\u00a0vitro model of blood-brain barrier","volume":"310","author":"Monnaert","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.arcmed.2014.11.020_bib74","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00109-009-0488-6","article-title":"Functions of lipid raft membrane microdomains at the blood-brain barrier","volume":"87","author":"Dodelet-Devillers","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.arcmed.2014.11.020_bib75","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bph.12218","article-title":"Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells","volume":"169","author":"H\u00fclper","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10623320109051566","article-title":"Lipid polarity in brain capillary endothelial cells","volume":"8","author":"Tewes","year":"2001","journal-title":"Endothelium"},{"key":"10.1016\/j.arcmed.2014.11.020_bib77","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.bmcl.2006.01.031","article-title":"How cyclodextrins can mask their toxic effects on the blood-brain barrier","volume":"16","author":"Binkowski-Machut","year":"2006","journal-title":"Biorg Med Chem Lett"},{"key":"10.1016\/j.arcmed.2014.11.020_bib78","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2174\/13816128113199990466","article-title":"Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration","volume":"20","author":"Chaves","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.arcmed.2014.11.020_bib79","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/jcbfm.2009.214","article-title":"Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells","volume":"30","author":"Zhong","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.arcmed.2014.11.020_bib80","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10545-012-9583-x","article-title":"Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability","volume":"36","author":"Pontikis","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.arcmed.2014.11.020_bib81","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BJ20041377","article-title":"Depletion of Caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight-junction proteins","volume":"387","author":"Lambert","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.arcmed.2014.11.020_bib82","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0171-9335(99)80074-0","article-title":"Rapid reduction of MDCK cell cholesterol by methyl-\u03b2-cyclodextrin alters steady state transepithelial electrical resistance","volume":"78","author":"Francis","year":"1999","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib83","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2009.06.018","article-title":"The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats","volume":"379","author":"Hamid","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijpharm.2013.05.055","article-title":"Effects of pharmaceutical excipients on membrane permeability in rat small intestine","volume":"453","author":"Takizawa","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-5793(03)00059-0","article-title":"Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells","volume":"536","author":"Yunomae","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2014.11.020_bib86","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.coph.2013.08.010","article-title":"Clinical relevance of drug efflux pumps in the gut","volume":"13","author":"Misaka","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib87","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920010794328850","article-title":"Targeting intestinal transporters for optimizing oral drug absorption","volume":"11","author":"Varma","year":"2010","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.arcmed.2014.11.020_bib88","doi-asserted-by":"crossref","first-page":"e84856","DOI":"10.1371\/journal.pone.0084856","article-title":"Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis","volume":"9","author":"Fenyvesi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2014.11.020_bib89","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2007.08.049","article-title":"Physicochemical properties of water and its effect on drug delivery. A commentary","volume":"354","author":"Loftsson","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib90","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-3495(98)74058-5","article-title":"The size of the unstirred layer as a function of the solute diffusion coefficient","volume":"75","author":"Pohl","year":"1998","journal-title":"Biophys J"},{"key":"10.1016\/j.arcmed.2014.11.020_bib91","first-page":"83","article-title":"Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes","volume":"61","author":"Loftsson","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.arcmed.2014.11.020_bib92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2007.04.029","article-title":"Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins","volume":"342","author":"Brewster","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib93","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1021\/es050556s","article-title":"Quantifying the effect of medium composition on the diffusive mass transfer of hydrophobic organic chemicals through unstirred boundary layers","volume":"39","author":"Mayer","year":"2005","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib94","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/bm3008633","article-title":"\u03b2-Cyclodextrin-poly(\u03b2-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier","volume":"13","author":"Gil","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.arcmed.2014.11.020_bib95","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-0270(97)00110-6","article-title":"A simple method, using 2-hydroxypropyl-\u03b2-cyclodextrin, of administering \u03b1-chloralose at room temperature","volume":"77","author":"Storer","year":"1997","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.arcmed.2014.11.020_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.02.091","article-title":"A functional in\u00a0vitro model of rat blood-brain barrier for molecular analysis of efflux transporters","volume":"1150","author":"Perri\u00e8re","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib97","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1248\/cpb.40.3042","article-title":"Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits","volume":"40","author":"Watanabe","year":"1992","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.arcmed.2014.11.020_bib98","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1023\/A:1018997101542","article-title":"Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of \u03b2-cyclodextrin derivatives on \u03b1-chymotryptic degradation and enteral absorption of insulin in rats","volume":"11","author":"Shao","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib99","first-page":"287","article-title":"Cyclodextrins and cellular interactions","volume":"Chapter 15","author":"Dreyfuss","year":"2011"},{"key":"10.1016\/j.arcmed.2014.11.020_bib100","first-page":"623","article-title":"Pharmacokinetics of intranasal formulations of dihydroergotamine","volume":"46","author":"Van der Kuy","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib101","unstructured":"Merkus FWHM, inventor and assignee. Nasal melatonin compositions. US Patent 6,007,834.\u00a01998."},{"key":"10.1016\/j.arcmed.2014.11.020_bib102","series-title":"Proceedings of the Eighth International Symposium on Cyclodextrins","first-page":"387","article-title":"Effects of cyclodextrins on nasal absorption and analgesic activity of opioids in rats","author":"Kondo","year":"1996"},{"key":"10.1016\/j.arcmed.2014.11.020_bib103","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF00318047","article-title":"Methylated \u03b2-cyclodextrins are able to improve the nasal absorption of salmon calcitonin","volume":"56","author":"Schipper","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.arcmed.2014.11.020_bib104","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jpba.2009.05.031","article-title":"Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization","volume":"50","author":"Al Omaria","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.arcmed.2014.11.020_bib105","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jps.20350","article-title":"Evaluation of buccal methyl-\u03b2-cyclodextrin toxicity on human oral epithelial cell culture model","volume":"94","author":"Boulmedarat","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib106","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0028-2243(92)90245-T","article-title":"Intranasal administration of estradiol in combination with progesterone to oophorectomized women: a pilot study","volume":"43","author":"Hermens","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(02)00345-9","article-title":"The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa","volume":"246","author":"Asai","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib108","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5173(90)90132-N","article-title":"Studies of cyclodextrin inclusion complexes. I: The salbutamol-cyclodextrin complex as studied by phase solubility and DSC","volume":"63","author":"Cabral Marques","year":"1990","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib109","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-5173(91)90330-Q","article-title":"Studies of cyclodextrin inclusion complexes. III. The pulmonary absorption of \u03b2-, DM-\u03b2- and HP-\u03b2-cyclodextrin in rabbits","volume":"77","author":"Cabral Marques","year":"1991","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-5173(91)90331-H","article-title":"Studies of cyclodextrin inclusion complexes. IV: The pulmonary absorption of salbutamol from a complex with 2-hydroxypropyl-\u03b2-cyclodextrin in rabbits","volume":"77","author":"Cabral Marques","year":"1991","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib111","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejpb.2009.05.002","article-title":"Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid\/cyclodextrin inclusion complexes","volume":"73","author":"Cabral-Marques","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib112","first-page":"63","article-title":"Administration as hydoxypropyl-\u03b2-cyclodextrin complexes does not slow rates of pulmonary drug absorption in rats","volume":"4","author":"Wall","year":"1994","journal-title":"STP Pharma Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib113","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejps.2012.10.024","article-title":"A preclinical pharmacokinetic modeling approach to the biopharmaceutical characterization of immediate and microsphere-based sustained release pulmonary formulations of rifampicin","volume":"48","author":"Doan","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib114","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1021\/jp4060632","article-title":"Cyclodextrin derivatives conjugated with aromatic moieties as pH-responsive drug carriers for anthracycline","volume":"117","author":"Swiech","year":"2013","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.arcmed.2014.11.020_bib115","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1021\/bm401340g","article-title":"Design and evaluation of folate-appended \u03b1, \u03b2-, and \u03b3-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in\u00a0vitro and in\u00a0vivo","volume":"14","author":"Okamatsu","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.arcmed.2014.11.020_bib116","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/bc400015r","article-title":"Folate-appended \u03b2-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in\u00a0vitro and in\u00a0vivo","volume":"24","author":"Okamatsu","year":"2013","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib117","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0939-6411(01)00166-7","article-title":"Passive skin penetration and its quantification in\u00a0vitro","volume":"52","author":"Moser","year":"2001","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib118","series-title":"Handbook of Experimental Pharmacology, Vol. 197: Drug Delivery","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-3-642-00477-3_15","article-title":"Carriers in the topical treatment of the skin","author":"Korting","year":"2010"},{"key":"10.1016\/j.arcmed.2014.11.020_bib119","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1529-8019.2012.01464.x","article-title":"A look at emerging delivery systems for topical drug products","volume":"24","author":"Fireman","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.arcmed.2014.11.020_bib120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(01)00761-X","article-title":"Cyclodextrins in topical drug formulations: theory and practice","volume":"225","author":"Loftsson","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10717544.2013.801533","article-title":"Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems","volume":"20","author":"Chen","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.arcmed.2014.11.020_bib122","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1023\/A:1016060403438","article-title":"Current status and future prospects of transdermal drug delivery","volume":"13","author":"Guy","year":"1996","journal-title":"Pharm Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib123","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1529-8019.2012.01501.x","article-title":"A review of delivery systems in cosmetics","volume":"25","author":"Hougeir","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.arcmed.2014.11.020_bib124","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.colsurfb.2013.04.045","article-title":"Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-\u03b2-cyclodextrin on ex\u00a0vivo human skin permeation and in\u00a0vivo topical anti-imflammatory efficacy","volume":"110","author":"Vega","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.arcmed.2014.11.020_bib125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijpharm.2010.04.029","article-title":"Enhancement of stability and skin permeation by sucrose stearate and cylodextrins in progesterone nanoemulsions","volume":"393","author":"Klang","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.2042-7158.1992.tb03574.x","article-title":"Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-\u03b2-cyclodextrin and penetration enhancers","volume":"44","author":"Uekama","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib127","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ejpb.2007.12.015","article-title":"Influence of hydroxypropyl-\u03b2-cyclodextrin on transdermal penetration and photostability of avobenzone","volume":"69","author":"Yang","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0033-1349089","article-title":"The effect of \u03b2-cyclodextrin on percutaneous absorption of commonly used Eusolex sunscreens","volume":"63","author":"Shokri","year":"2013","journal-title":"Drug Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib129","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical application of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib131","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.arcmed.2014.11.020_bib132","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jps.2600841015","article-title":"Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins","volume":"84","author":"Sharma","year":"1995","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib133","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1263\/jbb.102.369","article-title":"Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins","volume":"102","author":"Hamada","year":"2006","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.arcmed.2014.11.020_bib134","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejpb.2006.11.025","article-title":"Paclitaxel\/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion\u2014formulation and stability","volume":"66","author":"Bouquet","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib135","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1002\/jps.22666","article-title":"Randomly methylated \u03b2-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer","volume":"100","author":"Fenyvesi","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib136","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2010.03.012","article-title":"Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles","volume":"145","author":"Ag\u00fceros","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.arcmed.2014.11.020_bib137","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0168-3659(87)90084-8","article-title":"Amorphous water-soluble derivatives of cyclodextrins: from test tube to patient","volume":"6","author":"Pitha","year":"1987","journal-title":"J Contr Rel"},{"key":"10.1016\/j.arcmed.2014.11.020_bib138","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0024-3205(83)90304-1","article-title":"Rescue from hypervitaminosis A or potentiation of retinoid toxicity by different modes of cyclodextrin administration","volume":"32","author":"Pitha","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib139","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-3476(87)80109-9","article-title":"Severe hypervitaminosis A in siblings: evidence of variable tolerance to retinol intake","volume":"111","author":"Carpenter","year":"1987","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcmed.2014.11.020_bib140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2008.10.010","article-title":"Preclinical pharmacology of sugammadex","volume":"24","author":"Bom","year":"2009","journal-title":"J Crit Care"},{"key":"10.1016\/j.arcmed.2014.11.020_bib141","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.7150\/ijms.6254","article-title":"Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures","volume":"10","author":"Palanca","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib142","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.anclin.2010.08.014","article-title":"Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions","volume":"28","author":"Akha","year":"2010","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.arcmed.2014.11.020_bib143","first-page":"57","article-title":"Sugammadex as a reversal agent for neuromuscular block: an evidence-based review","volume":"8","author":"Schaller","year":"2013","journal-title":"Core Evid"},{"key":"10.1016\/j.arcmed.2014.11.020_bib144","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1358\/dot.2012.48.6.1813474","article-title":"Sugammadex, the first selective relaxant binding agent for neuromuscular block reversal","volume":"48","author":"Stair","year":"2012","journal-title":"Drugs Today"},{"key":"10.1016\/j.arcmed.2014.11.020_bib145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/ACO.0b013e32834f012d","article-title":"Is sugammadex economically viable for routine use?","volume":"25","author":"Fuchs-Buder","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib146","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/1568026613666131127160118","article-title":"Collaborative development of 2-hydroxypropyl-\u03b2-cyclodextrin for the treatment of Niemann-Pick type C1 disease","volume":"14","author":"Ottinger","year":"2014","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib147","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1194\/jlr.R047837","article-title":"Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin","volume":"55","author":"Vance","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib148","doi-asserted-by":"crossref","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2014.11.020_bib149","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","article-title":"Genetic variations and treatments that affect the lifespan of the NPC1 mouse","volume":"49","author":"Liu","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1203\/PDR.0b013e3181df4623","article-title":"2-hydroxypropyl-\u03b2-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease","volume":"68","author":"Ward","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib151","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib152","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1523\/JNEUROSCI.1317-11.2011","article-title":"Unesterified cholesterol accumulation in late endosomes\/lysosomes causes neurodegeneration and is\u00a0prevented by driving cholesterol export from this compartment","volume":"31","author":"Aqul","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib153","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2014.11.020_bib154","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","article-title":"Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life","volume":"68","author":"Ramirez","year":"2010","journal-title":"Pediat Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib155","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1093\/hmg\/dds322","article-title":"Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a \u03b2-cyclodextrin","volume":"21","author":"Maulik","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.arcmed.2014.11.020_bib156","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm1073","article-title":"Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone","volume":"10","author":"Griffin","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2014.11.020_bib157","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1084\/jem.20121239","article-title":"Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease","volume":"209","author":"Yao","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2014.11.020_bib158","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1471-4159.2006.04017.x","article-title":"Effects of the cholesterol-lowering compound methyl-\u03b2-cyclodextrin in models of \u03b1-synucleinopathy","volume":"98","author":"Bar-On","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib159","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/jm401883v","article-title":"Structural modifications of neuroprotective anti-Parkinsonian (\u2212)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in\u00a0vivo efficacy of the parent molecule","volume":"57","author":"Modi","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00210-012-0804-5","article-title":"HP-\u03b2-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats","volume":"386","author":"Tao","year":"2013","journal-title":"Naunyn-Schmiedebers Arch Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib161","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WNR.0b013e32834ee47c","article-title":"Neuroprotective effect of hydroxypropyl-\u03b2-cyclodextrin in hypoxia-ischemia","volume":"23","author":"Rivers","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.arcmed.2014.11.020_bib162","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2010.10.015","article-title":"Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model","volume":"403","author":"\u00c7\u0131rpanl\u0131","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib163","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nano.2009.10.001","article-title":"Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas","volume":"6","author":"Alizadeh","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arcmed.2014.11.020_bib164","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.jcbfm.9600602","article-title":"Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) \u03b1-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent","volume":"28","author":"Lahrech","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.arcmed.2014.11.020_bib165","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1194\/jlr.M028241","article-title":"Cyclodextrin mediates rapid changes in lipid balance in Npc1\u2212\/\u2212 mice without carrying cholesterol through the bloodstream","volume":"53","author":"Taylor","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib166","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M000257","article-title":"Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestrated cholesterol as bile acid","volume":"51","author":"Liu","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib167","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1074\/jbc.M113.506246","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy","volume":"289","author":"Song","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib168","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1267\/ahc.13033","article-title":"ACAT1-associated late endosomes\/lysosomes significantly improve impaired intracellular cholesterol metabolism and the survival of Niemann-Pick type C mice","volume":"47","author":"Kamikawa","year":"2014","journal-title":"Acta Histochem Cytochem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib169","unstructured":"National Niemann Pick Disease Foundation. http:\/\/www.nnpdf.org\/cyclodextrin.html. Accessed 16 September\u00a02014."},{"key":"10.1016\/j.arcmed.2014.11.020_bib170","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.bbadis.2012.06.005","article-title":"Neuroprotection by lowering cholesterol: a decrease in membrane cholesterol content reduces transporter-mediated glutamate release from brain nerve terminals","volume":"1822","author":"Krisanova","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2014.11.020_bib171","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1471-4159.2005.03001.x","article-title":"Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution","volume":"92","author":"Abulrob","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib172","doi-asserted-by":"crossref","first-page":"26709","DOI":"10.1074\/jbc.M114.586156","article-title":"A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology","volume":"289","author":"Paton","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib173","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbrc.2009.06.077","article-title":"Cyclodextrins promote protein aggregation posing risks for therapeutic applications","volume":"386","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2014.11.020_bib174","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2014.11.020_bib175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","article-title":"Altered cholesterol homeostasis contributes to enhanced excitotoxicity","volume":"115","author":"del Toro","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib176","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/mp3003946","article-title":"Self-assembling modified \u03b2-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's disease","volume":"10","author":"Godinho","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib177","doi-asserted-by":"crossref","first-page":"11195","DOI":"10.1128\/JVI.02559-06","article-title":"Cyclodextrins inhibit replication of scrapie prion protein in cell culture","volume":"81","author":"Prior","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib178","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nbd.2004.10.008","article-title":"Inhibition of p53-related apoptosis had no effect on PrPSc accumulation and prion disease incubation time","volume":"18","author":"Engelstein","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.arcmed.2014.11.020_bib179","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejpb.2008.05.012","article-title":"Comparison of nanosuspensions and hydroxypropyl-\u03b2-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice","volume":"70","author":"Ben Zirar","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1365-2141.1997.972911.x","article-title":"Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia","volume":"97","author":"Schwartz","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib181","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treament","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2014.11.020_bib182","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijantimicag.2006.04.006","article-title":"Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman","volume":"28","author":"Elter","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.arcmed.2014.11.020_bib183","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jamaneurol.2013.1043","article-title":"Isolated central nervous system histoplasmosis presenting with ischemic pontine stroke and meningitis in an immune-competent patient","volume":"70","author":"Nguyen","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib184","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/AAC.00332-06","article-title":"Comparison of itraconazole and fluconazole treatments in a murine model of coccoidal meningitis","volume":"51","author":"Kamberi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arcmed.2014.11.020_bib185","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejps.2010.01.003","article-title":"Pre-clinical pharmacokinetics evaluation of an anticonvulsant candidate benzaldehyde semicarbazone free and included in \u03b2-cyclodextrin","volume":"39","author":"Kaiser","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib186","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-291X(02)00865-3","article-title":"An effective anticonvulsant prepared following a host-guest strategy that uses hydroxy-\u03b2-cyclodextrin and benzaldehyde semicarbazone","volume":"296","author":"Beraldo","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2014.11.020_bib187","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1528-1157.1997.tb01084.x","article-title":"Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus","volume":"38","author":"L\u00f6scher","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.arcmed.2014.11.020_bib188","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/epi.12134","article-title":"Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers","volume":"54","author":"Clark","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.arcmed.2014.11.020_bib189","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/epi.12165","article-title":"Intravenous topiramate: safety and pharmacokinetics following single dose in patients with epilepsy or migraines taking oral topiramate","volume":"54","author":"Clark","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.arcmed.2014.11.020_bib190","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1002\/jps.21283","article-title":"Characterization of an inclusion complex between cladribine and 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"97","author":"van Axel Castelli","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib191","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa0902533","article-title":"A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis","volume":"362","author":"Giovannonni","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2014.11.020_bib192","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2174\/092986707780090972","article-title":"The search for a topical dual action spermicide\/microbicide","volume":"14","author":"Hughes","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib193","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.coph.2013.08.007","article-title":"Cyclodextrin derivatives as anti-infectives","volume":"13","author":"Karginov","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib194","first-page":"173","article-title":"Effects of cyclodextrins on RBC aggregation and blood viscosity","volume":"36","author":"Toyama","year":"2007","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.arcmed.2014.11.020_bib195","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jps.2600810610","article-title":"Hydroxypropyl cyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans","volume":"81","author":"Irie","year":"1992","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.arcmed.2014.11.020_bib196","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4168\/aair.2013.5.6.402","article-title":"Effect of cholesterol depletion on interleukin-8 production in human respiratory epithelial cells","volume":"5","author":"Kim","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib197","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1194\/jlr.M041954","article-title":"Cholesterol lowering drug may influence cellular immune response by altering MHC II function","volume":"54","author":"Roy","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib198","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2046-2395-1-6","article-title":"Aging, immunosenescence and membrane rafts: the lipid connection","volume":"1","author":"Fulop","year":"2012","journal-title":"Longev Healthspan"},{"key":"10.1016\/j.arcmed.2014.11.020_bib199","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0047-6374(01)00274-3","article-title":"Cyclodextrin modulation of T lymphocyte signal transduction with aging","volume":"122","author":"F\u00fcl\u00f6p","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.arcmed.2014.11.020_bib200","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.febslet.2005.01.076","article-title":"Involvement of CD14 in the inhibitory effects of dimethyl-\u03b1-cyclodextrin on lipopolysaccharide signaling in macrophages","volume":"579","author":"Motoyama","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2014.11.020_bib201","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1023\/A:1010983111816","article-title":"Inhibitory effects of novel hydrophilic cyclodextrin derivatives on nitric oxide production in macrophages stimulated with lipopolysaccharide","volume":"18","author":"Arima","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.arcmed.2014.11.020_bib202","doi-asserted-by":"crossref","first-page":"E1402","DOI":"10.1073\/pnas.1400530111","article-title":"Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium","volume":"111","author":"Nociari","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2014.11.020_bib203","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2353\/ajpath.2006.050959","article-title":"Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents","volume":"168","author":"Li","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib204","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/1471-2407-10-647","article-title":"Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells","volume":"10","author":"Raghu","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2014.11.020_bib205","doi-asserted-by":"crossref","first-page":"18145","DOI":"10.1074\/jbc.M512566200","article-title":"Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2014.11.020_bib206","first-page":"1","article-title":"Design and evaluation of folate-appended methyl-\u03b2-cyclodextrin as an active pharmaceutical ingredient for cancer treatment","volume":"28","author":"Motoyama","year":"2014","journal-title":"Cyclodextrin News"},{"key":"10.1016\/j.arcmed.2014.11.020_bib207","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2745\/dds.28.99","article-title":"Potential use of folate-appended methyl-\u03b2-cyclodextrin as a novel antitumor agent","volume":"28","author":"Motoyama","year":"2013","journal-title":"Drug Deliv Syst"},{"key":"10.1016\/j.arcmed.2014.11.020_bib208","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2013.04.071","article-title":"Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-\u03b2-cyclodextrin","volume":"452","author":"Onodera","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.arcmed.2014.11.020_bib209","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-2952(97)00157-3","article-title":"A basic compositional requirement of agents having heparin-like cell-modulating activities","volume":"54","author":"Weisz","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.arcmed.2014.11.020_bib210","series-title":"Biocatalysis and Biomimetics. ACS Symposium Series 392","first-page":"19","article-title":"Interdisciplinary challenges. Control of angiogenesis","author":"Folkman","year":"1989"},{"key":"10.1016\/j.arcmed.2014.11.020_bib211","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1126\/science.2467380","article-title":"Control of angiogenesis with synthetic heparin substitutes","volume":"243","author":"Folkman","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2014.11.020_bib212","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.joca.2008.01.005","article-title":"Cyclodextrin polysulphate protects articular cartilage in experimental lapine knee osteoarthritis","volume":"16","author":"Groeneboer","year":"2008","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440914002690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440914002690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:44:11Z","timestamp":1759261451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440914002690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":212,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0188440914002690"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2014.11.020","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclodextrins, Blood\u2013Brain Barrier, and Treatment of Neurological Diseases","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2014.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}